Chronic Obstructive Pulmonary Disease and Multimorbidity: Insights from a National Claims Administrative Database.

IF 4.1 3区 医学 Q2 RESPIRATORY SYSTEM
Álvaro Javier Burgos-Cárdenas, Rodolfo J Dennis, Carlos A Torres-Duque, Alejandro Casas, Mauricio Gonzalez-Garcia, Giancarlo Buitrago
{"title":"Chronic Obstructive Pulmonary Disease and Multimorbidity: Insights from a National Claims Administrative Database.","authors":"Álvaro Javier Burgos-Cárdenas, Rodolfo J Dennis, Carlos A Torres-Duque, Alejandro Casas, Mauricio Gonzalez-Garcia, Giancarlo Buitrago","doi":"10.2147/COPD.S622073","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To estimate the prevalence of diagnosed chronic obstructive pulmonary disease (COPD) and characterize the frequency and distribution of multimorbidity among individuals with and without COPD in Colombia's contributory health system.</p><p><strong>Patients and methods: </strong>We conducted a cross-sectional study using administrative healthcare data from the Capitation Unit Sufficiency Database (Unidad de Pago por Capitación, UPC) and the Unique Enrollees Database (Base de Datos Única de Afiliados, BDUA). An electronic algorithm was used to identify individuals with a COPD diagnosis and to estimate diagnosed COPD prevalence among all affiliates during 2018-2019. We also estimated the prevalence of selected health conditions among individuals with and without COPD. Differences between groups were assessed in two steps. First, standardized mean differences (SMDs) were calculated for prevalence estimates. Second, conditions with SMDs of approximately 0.1 or greater were further evaluated using prevalence ratios (PRs) adjusted for sex, region, age, insurer, and prior healthcare service utilization estimated with Poisson regression with robust variance and 95% confidence intervals.</p><p><strong>Results: </strong>The study included 6,865,420 individuals. The nationwide prevalence of diagnosed COPD was 2.21% (95% CI, 2.20-2.22), with the highest prevalence observed in the Central region (2.77%; 95% CI, 2.74-2.79). In adjusted analyses, several conditions were more prevalent among individuals with COPD, including asthma (PR = 3.88; 95% CI, 2.88-5.23), sleep apnea (PR = 2.62; 95% CI, 2.05-3.35), heart failure (PR = 1.89; 95% CI, 1.29-2.78), ischemic heart disease (PR = 1.60; 95% CI, 1.26-2.03), hypertension (PR = 1.08; 95% CI, 1.02-1.15), and osteoporosis (PR = 2.34; 95% CI, 1.52-3.58), among others, were more prevalent among individuals with COPD. Lung cancer (PR = 6.41; 95% CI, 5.89-6.97) and breast cancer (PR = 1.17; 95% CI, 1.08-1.25) were also more prevalent in this population.</p><p><strong>Conclusion: </strong>Individuals with diagnosed COPD in Colombia's contributory health system had a substantial burden of multimorbidity, particularly respiratory and cardiovascular conditions. These findings support interdisciplinary care models and locally tailored strategies to address regional differences in diagnosed COPD.</p>","PeriodicalId":48818,"journal":{"name":"International Journal of Chronic Obstructive Pulmonary Disease","volume":"21 ","pages":"622073"},"PeriodicalIF":4.1000,"publicationDate":"2026-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13589997/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Chronic Obstructive Pulmonary Disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/COPD.S622073","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: To estimate the prevalence of diagnosed chronic obstructive pulmonary disease (COPD) and characterize the frequency and distribution of multimorbidity among individuals with and without COPD in Colombia's contributory health system.

Patients and methods: We conducted a cross-sectional study using administrative healthcare data from the Capitation Unit Sufficiency Database (Unidad de Pago por Capitación, UPC) and the Unique Enrollees Database (Base de Datos Única de Afiliados, BDUA). An electronic algorithm was used to identify individuals with a COPD diagnosis and to estimate diagnosed COPD prevalence among all affiliates during 2018-2019. We also estimated the prevalence of selected health conditions among individuals with and without COPD. Differences between groups were assessed in two steps. First, standardized mean differences (SMDs) were calculated for prevalence estimates. Second, conditions with SMDs of approximately 0.1 or greater were further evaluated using prevalence ratios (PRs) adjusted for sex, region, age, insurer, and prior healthcare service utilization estimated with Poisson regression with robust variance and 95% confidence intervals.

Results: The study included 6,865,420 individuals. The nationwide prevalence of diagnosed COPD was 2.21% (95% CI, 2.20-2.22), with the highest prevalence observed in the Central region (2.77%; 95% CI, 2.74-2.79). In adjusted analyses, several conditions were more prevalent among individuals with COPD, including asthma (PR = 3.88; 95% CI, 2.88-5.23), sleep apnea (PR = 2.62; 95% CI, 2.05-3.35), heart failure (PR = 1.89; 95% CI, 1.29-2.78), ischemic heart disease (PR = 1.60; 95% CI, 1.26-2.03), hypertension (PR = 1.08; 95% CI, 1.02-1.15), and osteoporosis (PR = 2.34; 95% CI, 1.52-3.58), among others, were more prevalent among individuals with COPD. Lung cancer (PR = 6.41; 95% CI, 5.89-6.97) and breast cancer (PR = 1.17; 95% CI, 1.08-1.25) were also more prevalent in this population.

Conclusion: Individuals with diagnosed COPD in Colombia's contributory health system had a substantial burden of multimorbidity, particularly respiratory and cardiovascular conditions. These findings support interdisciplinary care models and locally tailored strategies to address regional differences in diagnosed COPD.

慢性阻塞性肺疾病和多发病:来自国家索赔管理数据库的见解。
目的:估计诊断为慢性阻塞性肺疾病(COPD)的患病率,并表征哥伦比亚的缴费卫生系统中患有和不患有COPD的个体中多病的频率和分布。患者和方法:我们使用来自人均单位充足性数据库(Unidad de Pago por Capitación, UPC)和唯一注册者数据库(Base de Datos Única de Afiliados, BDUA)的行政保健数据进行了一项横断面研究。使用电子算法识别诊断为COPD的个体,并估计2018-2019年所有附属医院中诊断为COPD的患病率。我们还估计了COPD患者和非COPD患者中选定健康状况的患病率。两组之间的差异分两步评估。首先,计算患病率估计的标准化平均差异(SMDs)。其次,smd约为0.1或更高的情况进一步评估,使用患病率(pr)对性别、地区、年龄、保险公司和先前的医疗服务利用进行调整,用泊松回归估计,具有稳健方差和95%置信区间。结果:该研究包括6,865,420人。全国诊断为慢性阻塞性肺病的患病率为2.21% (95% CI, 2.20-2.22),中部地区的患病率最高(2.77%;95% CI, 2.74-2.79)。在调整后的分析中,COPD患者中有几种情况更为普遍,包括哮喘(PR = 3.88; 95% CI, 2.88-5.23)、睡眠呼吸暂停(PR = 2.62; 95% CI, 2.05-3.35)、心力衰竭(PR = 1.89; 95% CI, 1.29-2.78)、缺血性心脏病(PR = 1.60; 95% CI, 1.26-2.03)、高血压(PR = 1.08; 95% CI, 1.02-1.15)和骨质疏松症(PR = 2.34; 95% CI, 1.52-3.58)等,在COPD患者中更为普遍。肺癌(PR = 6.41; 95% CI, 5.89-6.97)和乳腺癌(PR = 1.17; 95% CI, 1.08-1.25)在该人群中也更为普遍。结论:在哥伦比亚的缴费卫生系统中,诊断为慢性阻塞性肺病的个体具有多重疾病的沉重负担,特别是呼吸和心血管疾病。这些发现支持跨学科护理模式和地方量身定制的策略,以解决慢性阻塞性肺病诊断的地区差异。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.80
自引率
10.70%
发文量
372
审稿时长
16 weeks
期刊介绍: An international, peer-reviewed journal of therapeutics and pharmacology focusing on concise rapid reporting of clinical studies and reviews in COPD. Special focus will be given to the pathophysiological processes underlying the disease, intervention programs, patient focused education, and self management protocols. This journal is directed at specialists and healthcare professionals
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书